MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view

Increasing evidence suggests that patients with diabetes, particularly type 2 diabetes (T2D), are characterized by an increased risk of developing different types of cancer, so cancer could be proposed as a new T2D-related complication. On the other hand, cancer may also increase the risk of develop...

Descripción completa

Detalles Bibliográficos

Autores principales:	Natalicchio, A., Montagnani, M., Gallo, M., Marrano, N., Faggiano, A., Zatelli, M.C., Mazzilli, R., Argentiero, A., Danesi, R., D’Oronzo, S., Fogli, S., Giuffrida, D., Gori, S., Ragni, A., Renzelli, V., Russo, A., Franchina, T., Tuveri, E., Sciacca, L., Monami, M., Cirino, G., Di Cianni, G., Colao, A., Avogaro, A., Cinieri, S., Silvestris, N., Giorgino, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245125/ https://www.ncbi.nlm.nih.gov/pubmed/37263082 http://dx.doi.org/10.1016/j.esmoop.2023.101573